Shanghai Fosun Pharmaceutical (Group) Co's market cap is currently ―. The company's EPS TTM is $0.127; its P/E ratio is 13.26; and it has a dividend yield of 3.52%. Shanghai Fosun Pharmaceutical (Group) Co is scheduled to report earnings on April 24, 2024, and the estimated EPS forecast is $0.06. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 22	Sep 22	Jun 22	Mar 22	Dec 21
Income Statement	-
Total Revenue	¥ 12.34B	-	¥ 10.96B	¥ 10.38B	¥ 11.96B
Gross Profit	¥ 6.08B	-	¥ 5.24B	¥ 4.52B	¥ 5.11B
EBIT	¥ 1.44B	-	¥ 1.72B	¥ 1.09B	¥ 1.58B
EBITDA	¥ 1.44B	-	¥ 1.72B	¥ 1.09B	¥ 1.58B
Net Income Common Stockholders	¥ 1.28B	-	¥ 1.08B	¥ 462.51M	¥ 1.17B
Balance Sheet	-
Cash, Cash Equivalents and Short-Term Investments	¥ 17.17B	¥ 0.00	¥ 14.64B	¥ 14.08B	¥ 14.55B
Total Assets	¥ 107.16B	-	¥ 98.80B	¥ 95.77B	¥ 93.29B
Total Debt	¥ 30.25B	¥ 0.00	¥ 29.99B	¥ 26.71B	¥ 24.25B
Net Debt	¥ 13.08B	¥ 0.00	¥ 15.34B	¥ 12.64B	¥ 9.70B
Total Liabilities	¥ 53.05B	-	¥ 51.07B	¥ 48.01B	¥ 44.92B
Stockholders Equity	¥ 44.58B	¥ 0.00	¥ 38.20B	¥ 38.33B	¥ 39.19B
Cash Flow	-
Free Cash Flow	¥ -369.02M	-	¥ -141.53M	¥ -633.43M	¥ -538.06M
Operating Cash Flow	-	-	-	-	-
Investing Cash Flow	¥ 138.37M	-	¥ -1.02B	¥ -1.47B	¥ -1.27B
Financing Cash Flow	¥ -514.65M	-	¥ 876.62M	¥ 1.54B	¥ -86.59M

Currency in CNY

Shanghai Fosun Pharmaceutical (Group) Co Earnings and Revenue History

Income Statement >

Shanghai Fosun Pharmaceutical (Group) Co Debt to Assets

Balance Sheet >

Shanghai Fosun Pharmaceutical (Group) Co Cash Flow

Cash Flow >

Shanghai Fosun Pharmaceutical (Group) Co Forecast EPS vs Actual EPS

Earnings >

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing